J.C. Penney is downgraded to 'sell,' and Red Robin is upgraded to 'buy.'
Stocks are lower despite the fact that unemployment claims dropped to the lowest level in 5 years last week.
Amgen, Celgene and Pharmacyclics see short interest drop recently.
There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
Raymond James is upgrading solar stocks and JC Penney is downgraded to 'neutral.'
AB InBev is upgraded to 'buy,' and Colgate-Palmolive is initiated with a 'sell.'
Dendreon is upgraded to 'outperform,' and Aeropostale is downgraded to 'neutral.'
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.